ResMed
312 hedge funds and large institutions have $3.87B invested in ResMed in 2014 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 93 increasing their positions, 130 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
312
Holders Change
-6
Holders Change %
-1.89%
% of All Funds
8.97%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.14%
New
29
Increased
93
Reduced
130
Closed
31
Calls
$30.8M
Puts
$27.5M
Net Calls
+$3.33M
Net Calls Change
+$65.7M
Top Buyers
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$73.1M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$36.6M |
| 3 |
ICP
Indus Capital Partners
New York
|
+$17.7M |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$7.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.1M |
Top Sellers
| 1 |
Bank of New York Mellon
New York
|
-$42.7M |
| 2 |
UIM
USS Investment Management
London,
United Kingdom
|
-$35.9M |
| 3 |
LCG
Luxor Capital Group
New York
|
-$35.1M |
| 4 |
GAM
Gotham Asset Management
New York
|
-$25.9M |
| 5 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$24.4M |
